market cap nvo between 1 january 2000 and 31 january 2023

On January 31, 2023, Novo Nordisk A-S (NVO) had a market capitalization of $297.6B, based on 4.51B shares at a price of $65.94.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
January 2023
$65.94
60,031,400
4,513,200,000
$297,609,885,720.00
December 2022
$64.31
56,107,600
4,522,800,000
$290,850,413,280.00
November 2022
$59.20
58,247,800
4,522,800,000
$267,769,660,320.00
October 2022
$51.72
49,459,400
4,522,800,000
$233,901,124,800.00
September 2022
$47.34
59,285,800
4,537,000,000
$214,780,672,600.00
August 2022
$50.41
111,234,400
4,537,000,000
$228,728,318,000.00
July 2022
$54.85
43,203,000
4,537,000,000
$248,857,172,200.00
June 2022
$52.66
54,052,000
4,552,200,000
$239,729,777,280.00
May 2022
$52.18
69,747,400
4,552,200,000
$237,513,766,320.00
April 2022
$53.88
61,997,400
4,552,200,000
$245,258,879,400.00
March 2022
$52.48
63,493,000
4,566,600,000
$239,667,954,480.00
February 2022
$48.19
50,862,600
4,566,600,000
$220,074,500,520.00
January 2022
$46.75
73,296,600
4,566,600,000
$213,490,376,640.00
December 2021
$52.43
57,472,800
4,581,200,000
$240,185,902,320.00
November 2021
$50.01
37,584,400
4,581,200,000
$229,098,940,200.00
October 2021
$51.55
34,219,600
4,581,200,000
$236,175,519,840.00
September 2021
$44.94
39,668,400
4,599,241,000
$206,705,987,883.50
August 2021
$46.80
56,302,000
4,599,241,000
$215,231,600,925.20
July 2021
$43.11
36,951,200
4,599,241,000
$198,283,857,764.30
June 2021
$39.00
38,711,600
4,612,600,000
$179,896,935,120.00
May 2021
$36.73
40,774,200
4,612,600,000
$169,438,787,140.00
April 2021
$34.43
31,672,800
4,612,600,000
$158,808,589,180.00
March 2021
$31.39
41,371,200
4,632,293,600
$145,403,527,039.76
February 2021
$32.71
48,314,400
4,632,293,600
$151,501,478,334.80
January 2021
$31.95
38,500,600
4,632,293,600
$147,992,979,162.16